Exclusive

Publication

Byline

Location

US Patent Issued to AB Studio on April 21 for "Heteromultimeric proteins and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,622, issued on April 21, was assigned to AB Studio Inc. (Hayward, Calif.). "Heteromultimeric proteins and methods of use thereof" was inve... Read More


US Patent Issued to ALLOGENE THERAPEUTICS, PFIZER on April 21 for "DLL3 targeting chimeric antigen receptors and binding agents" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,623, issued on April 21, was assigned to ALLOGENE THERAPEUTICS INC. (South San Francisco, Calif.) and PFIZER INC. (New York). "DLL3 target... Read More


US Patent Issued to NovoMab BioPharmaceuticals on April 21 for "Antibody that specifically binds to human CTLA4 and medicaments and kits comprising the same" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,624, issued on April 21, was assigned to NovoMab BioPharmaceuticals Inc (Nanjing, China). "Antibody that specifically binds to human CTLA4... Read More


US Patent Issued to Y-BIOLOGICS, IntoCell on April 21 for "Antibody binding specifically to B7-H3 and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,625, issued on April 21, was assigned to Y-BIOLOGICS INC. (Daejeon, South Korea) and IntoCell Inc. (Daejeon, South Korea). "Antibody bindi... Read More


US Patent Issued to Paragon Therapeutics on April 21 for "Alpha4Beta7 integrin binding proteins and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,627, issued on April 21, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.). "Alpha4Beta7 integrin binding proteins and methods of... Read More


US Patent Issued on April 21 for "Antibodies targeting integrin beta-2" (Canadian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,628, issued on April 21. "Antibodies targeting integrin beta-2" was invented by Sachdev Singh Sidhu (Toronto). According to the abstract*... Read More


US Patent Issued to Surrozen Operating on April 21 for "Monospecific anti-frizzled antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,629, issued on April 21, was assigned to Surrozen Operating Inc. (South San Francisco, Calif.). "Monospecific anti-frizzled antibodies and... Read More


US Patent Issued to MONTEFIORE MEDICAL CENTER on April 21 for "CD25 chimeric antigen receptors and uses thereof" (New York Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,630, issued on April 21, was assigned to MONTEFIORE MEDICAL CENTER (Bronx, N.Y.). "CD25 chimeric antigen receptors and uses thereof" was i... Read More


US Patent Issued to REMD Biotherapeutics on April 21 for "Antibodies which bind human endothelin receptor a (ET a R)" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,631, issued on April 21, was assigned to REMD Biotherapeutics Inc (Camarillo, Calif.). "Antibodies which bind human endothelin receptor a ... Read More


US Patent Issued to Apexigen on April 21 for "Anti-CD40 antibodies and methods of use" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,632, issued on April 21, was assigned to Apexigen Inc. (Boston). "Anti-CD40 antibodies and methods of use" was invented by Yongke Zhang (P... Read More